Cart
sales@molnova.com
Sigma-1 receptor antagonist 2
CAS No. 1639220-15-7
Sigma-1 receptor antagonist 2( —— )
Catalog No. M26444 CAS No. 1639220-15-7
Sigma-1 receptor antagonist 2 is a more potent and selective antagonist of sigma 1 receptor (σ1 R, Ki = 3.88 nM) than σ2 receptor (Ki = 1288 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 107 | In Stock |
|
| 5MG | 98 | In Stock |
|
| 10MG | 164 | In Stock |
|
| 25MG | 276 | In Stock |
|
| 50MG | 384 | In Stock |
|
| 100MG | 520 | In Stock |
|
| 200MG | 697 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSigma-1 receptor antagonist 2
-
NoteResearch use only, not for human use.
-
Brief DescriptionSigma-1 receptor antagonist 2 is a more potent and selective antagonist of sigma 1 receptor (σ1 R, Ki = 3.88 nM) than σ2 receptor (Ki = 1288 nM).
-
DescriptionSigma-1 receptor antagonist 2 is a more potent and selective antagonist of sigma 1 receptor (σ1 R, Ki = 3.88 nM) than σ2 receptor (Ki = 1288 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetSigma receptor
-
RecptorAldose reductase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1639220-15-7
-
Formula Weight375.9
-
Molecular FormulaC20H26ClN3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 86.67 mg/mL (230.57 mM)
-
SMILESCOc1ccc(cc1)-c1nc(C)c(Cl)c(OCCCN2CCCCC2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Carrington AL, et al. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats. Diabetologia. 1991 Jun;34(6):397-401.
molnova catalog
related products
-
MIN-101
MIN-101 (Roluperidone, CYR-101, MT-210) is a higly potent 5-HT2A and sigma 2 receptor antagonist.
-
BD1063
BD1063 is a potent and selective sigma 1(σ1) receptor antagonist(Ki = 9 nM).
-
Oritavancin diphosph...
Oritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic which is being developed for the treatment of serious Gram-positive bacterial infections.
